Astrazeneca and European Union strike deal to end vaccine supply dispute

AstraZeneca Plc and the European Union ended months of bitter legal wrangling over vaccine supplies with a deal to provide millions of extra doses to the bloc by early next year. 
 

The deal ends a blame game over the EU’s slow start in vaccinating its 448 million population as the U.S. and the U.K. raced to secure supplies that allowed them reopen their economies after a series of lockdowns. The pressure on supplies is now off with the EU managing to vaccinate 70% of adults.

Astra has so far delivered about 140 million doses to the EU. Under the agreement the